January 2020

Volume 28 Issue 1

Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Email: rkapur@hmpglobal.com
With proper commissural alignment in a TAVR patient, it is just a matter of engaging through the valve frame to access the coronaries.
Our policy at Mount Sinai Hospital is that for every percutaneous coronary intervention (PCI), we open the Runthrough NS. It is at 100% use in our interventions.
The cath lab is part of Parkland Memorial Hospital’s surgical services line. We typically perform 40-50 cases a week.
The collaborative care between the heart failure cardiologist, interventional cardiologist, and cardiothoracic surgeon was crucial in this case.
The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.
The time to telemedicine diagnosis from a center located hundreds of miles away from the originating patient is now 3.5 minutes.
Dr. Sachar presented 12-month data from the RANGER II SFA trial of the Ranger drug-coated balloon (DCB) (Boston Scientific) on November 5th at the 2019 Vascular InterVentional Advances (VIVA) conference in Las Vegas, Nevada.
This case utilizes a personalized approach for access, crossing, and treatment in order to achieve the best outcomes for the patient.
The written procedural information tool should meet the needs and expectations of the patient (including sensory information).
At this time, I believe we should use functional (FFR/NHPR) assessment of CAD for best decisions in this often elderly and frail patient group.